Special Issue "Advances in Pediatric Formulations Update"
Deadline for manuscript submissions: 1 March 2024 | Viewed by 12039
Interests: paediatric formulations; enhancing drug solubility; enhancing drug stability; enhancing drug permeability; design of prodrugs
Special Issues, Collections and Topics in MDPI journals
In the past several years, we have witnessed a remarkable interest and encouragement from the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the National Institute of Health (NIH) toward pediatric formulations. Despite all incentives offered by the above governmental agencies, however, there are still many therapeutic agents lacking pediatric-friendly drug delivery systems.
One of the major challenges that academic scientists have traditionally faced in this area is lack of funding and support for this line of research, with most of the governmental funding going toward the advancement of novel drug delivery systems with little impact on the pediatric population. Many novel and targeted drug delivery systems have faced many challenges when it comes to translation into pediatric patients. Some of these challenges include excipients’ toxicity and limited stability and shelf life, but the major limitation has been pursuing the most invasive drug delivery route (parenteral delivery). It is generally accepted that translational drug delivery systems are friendlier, easier to use, and can impact the safety and prosperity of children as well as profoundly prolong their adherence to medication when designed properly. Due to the lack of funding in this area, however, very few academician scientists have taken on the challenge and pursued this area for a career.
The purpose of this Special Issue of Children is to draw attention to the importance of pediatric formulations and to provide scientists with a platform to publish their novel research work in this area.
This Special Issue seeks novel topics pertaining to “Advances in Pediatric Formulations”. Original research as well as reviews will be considered for publication.
We look forward to receiving your contributions.
Dr. Hassan Almoazen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pediatric formulations
- drug stability
- drug solubility
- drug permeability
- prodrug design
- sublingual absorption
- oral absorption
- transdermal delivery
- pulmonary delivery
- fast dissolving tablets
- fast dissolving films
- oral niosomes